ODM-204: A novel dual inhibitor of CYP17A1 and androgen receptor for the treatment of castration-resistant prostate cancer—Preclinical data.
Year: 2015
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: Orion Corporation (Finland)
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2398096659
